Skip to main content

SusanP.PerrineMD

Pediatric Hematology & Oncology Boston, MA

Pediatric Anemia and Red Blood Cell Hematology, Pediatric Hematologic Oncology, Clinical Pharmacology

Professor, Pharmacology & Experimental Therapeutics, Medicine, Pediatrics, Boston University School of Medicine; Chief Medical Officer, Phoenicia BioScience Inc; Lecturer, Pediatrics, Tufts Medical Center

Dr. Perrine is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Perrine's full profile

Already have an account?

  • Office

    72 E Concord ST, L-602
    Boston, MA 02118
    Phone+1 617-335-7002

Summary

  • Dr. Susan Perrine is a pediatric hematologist/oncologist in Boston, MA and is affiliated with Boston University School of Medicine, Phoenicia BioSciences, and Tufts Medical Center. She obtained her MD and Pediatric residency at Tufts University School of Medicine, Fellowship at Children's Hospital Boston, SM from Harvard School of Public Health. She specializes in hemoglobinopathies and thalassemia, pediatric anemia, red cell hematology, clinical drug development and clinical trials. She directed an NIH-funded Translational Medicine laboratory program for 30 yrs, an NIH-supported Research Program in Hemoglobinopathies at Howard University School of Medicine, and new drug development in academia and biotech, as CSO, CMO, bringing 5 new INDs into clinical trials. She is interested in expanding medical care services to underserved populations, building Transition Programs and Medical Homes, and increasing utilization of new therapies in hemoglobinopathy patients who are not receiving regular care.

Clinical Expertise

  • Pediatric hematology / oncology, Hematologic oncology, Pediatrics, Clinical trials, drug development

Education & Training

  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1979 - 1980
  • Tufts Medical Center
    Tufts Medical CenterResidency, Pediatrics, 1976 - 1979
  • Harvard School of Public Health
    Harvard School of Public HealthSM, 1976 - 1978
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 1976

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1978 - 2026
  • DC State Medical License
    DC State Medical License 2014 - 2024
  • CA State Medical License
    CA State Medical License 1982 - 2021
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Harrington Scholar Innovator Award Harrington Disocvery Institute, 2016-2018

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Petition to Save Boston’s Tufts Children’s Hospital Garners More Than 56,000 Signatures
    Petition to Save Boston’s Tufts Children’s Hospital Garners More Than 56,000 SignaturesFebruary 4th, 2022

Grant Support

  • Development of a Clinical Hemoglobin ModulatorNIH2020–2023
  • Novel HDAC Inhibitors for Treatment of HemoglobinopathiesNIH NHLBI2018–2019
  • Virus Targeted Therapy for MalignancyNCI2017–2019
  • Clinical Development of a Hemoglobin ModulatorNIH2014–2017
  • Novel Globin Gene ModulatorsNIH NIDDK1998–2017
  • Globin Gene Expression in Sickle Cell Genotype Specific iPS cellsNIH2011–2016
  • Topical therapeutic to Promote Healing of Refractory WoundsNIH2013–2015
  • Selective HDACC 1/2 Inhibitors for HemoglobinopathiesNIH NHLBI2013–2014
  • Oral Agents to Stimulate Neutrophil ProductionNIH2010–2012
  • Development of an Oncogene Targeted TherapeuticNCI2009–2011

Professional Memberships

Other Languages

  • French

Industry Relationships

  • President, Chief Medical Officer, Phoenicia BioSciences IncDirecting clinical trials in thalassemia and sickle cell disease, EBV lymphoma, sickle cell leg ulcers2008 - Present